Posted by Michael Wonder on 10 Jul 2017
Drug industry to challenge NICE over new cost limits
10 July 2017 - The drug industry is going to court to challenge the authority of the National Institute for Health and Care Excellence.
The public body authorises spending by the NHS on expensive new treatments.
In March it announced a new policy to hold back spending on new drugs that might cost more than £20 million a year in any of their first three years of use.
